Lam Research Corporation LRCX MATCH Act Policy Scrutiny Highlights China Exposure Risks Amid Contrasting Valuation and NearTerm Momentum WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin Is Nuveen JPC stock in a good position today